The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

ContraVir Pharmaceuticals, Inc. - Focused on the Development and Commercialization of Targeted Antiviral Therapies

SNNLive spoke with James Sapirstein, CEO of ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) at The MicroCap Conference 2017 in New York City, NY.

Share With

Wednesday, February 07, 2018

   

© 2018 Stock News Now